Max Cotler
Company: GelMEDIX
Job title: Chief Operating Officer & President
Seminars:
Panel Discussion: Delving into the Evolution of Gene Therapy for Retinal Disease 10:30 am
day: Conference Day Two
Enhancing Cell & Gene Therapies With Advanced Hydrogel Platforms 11:00 am
Characterizing how hydrogel platforms impact localization and phenotype of injected cells Engineering formulations to improve cell viability Detailing the potential for tissue regenerationRead more
day: Conference Day Two